MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer

Histology and Histopathology

Volumn 28, Issue 4, 2013, Pages 481-492

  Liu, Min ^a,b   Li, Jin Song ^a,c   Tian, Dong Ping ^a   Huang, Bo ^a   Rosqvist, Seema ^d   Su, Min ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b NAVY GENERAL HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biomarker; Gastric cardiac carcinoma; Immunohistochemical staining; Minichromosome maintenance protein 2 (MCM2)

Indexed keywords

CELL CYCLE PROTEIN; CYCLINE; KI 67 ANTIGEN; MCM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CARDIA; CHEMISTRY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH MUCOSA; STOMACH TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARDIA; CELL CYCLE PROTEINS; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876439485     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Baisch H. and Gerdes J. (1987). Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki-67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet. 20, 387-391.
2. Barrett T.L., Smith K.J., Hodge J.J., Butler R., Hall F.W. and Skelton H.G. (1997). Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma. J. Am. Acad. Dermatol. 37, 430-437.
3. Bell S.P. and Dutta A. (2002). DNA replication in eukaryotic cells. Annu. Rev. Biochem. 71, 333-374.
4. Czyzewska J., Guzinska-Ustymowicz K., Pryczynicz A., Kemona A. and Bandurski R. (2009). Immunohistochemical assessment of Fhit protein expression in advanced gastric carcinomas in correlation with Helicobacter pylori infection and survival time. Folia Histochem. Cytobiol. 47, 47-53.
5. Davidson E.J., Morris L.S., Scott I.S., Rushbrook S.M., Bird K., Laskey R.A., Wilson G.E., Kitchener H.C., Coleman N. and Stern P.L. (2003). Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. Br. J. Cancer 88, 257-262.
6. Davies R.J., Freeman A., Morris L.S., Bingham S., Dilworth S., Scott I., Laskey R.A., Miller R. and Coleman N. (2002). Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 359, 1917-1919.
7. DeVita V.T., Hellman S. and Rosenberg S.A. (1993). Cancer: principles and practice of oncology. 4th ed. J.B. Lippincott Co. Philadelphia.
8. Fenoglio-Preiser C.M., Carneiro F., Correa P., Guilford P., Lambert B. and Megraud F. (2000). Gastric Carcinoma. In: Pathology and genetics of tumours of the digestive system. World Health Organization Classification of Tumours. Hamilton S.R. and Aaltomen L.A. (eds). IARCPress. Lyon. pp 39-52.
9. Freeman A., Morris L.S., Mills A.D., Stoeber K., Laskey R.A., Williams G.H. and Coleman N. (1999). Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. Clin. Cancer Res. 5, 2121-2132.
10. Gerdes J., Dallenbach F., Lennert K., Lemke H. and Stein H. (1984). Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hematol. Oncol. 2, 365-371.
11. Giaginis C., Giagini A., Tsourouflis G., Gatzidou E., Agapitos E., Kouraklis G. and Theocharis S. (2011). MCM-2 and MCM-5 expression in gastric adenocarcinoma: clinical significance and comparison with Ki-67 proliferative marker. Dig. Dis. Sci. 56, 777-785.
12. Going J.J., Keith W.N., Neilson L., Stoeber K., Stuart R.C. and Williams G.H. (2002). Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. Gut 50, 373-377.
13. Hall P.A., Levison D.A., Woods A.L., Yu C.C., Kellock D.B., Watkins J.A., Barnes D.M., Gillett C.E., Camplejohn R., Dover R., Waseem N.H. and Lane D.F. (1990). Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J. Pathol. 162, 285-294.
14. Hilton D.A., Love S., Barber R., Ellison D. and Sandeman D.R. (1998). Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery 42, 724-729.
15. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E. and Thun M.J. (2003). Cancer statistics, 2003. CA Cancer J. Clin. 53, 5-26.
16. Kato H., Miyazaki T., Fukai Y., Nakajima M., Sohda M., Takita J., Masuda N., Fukuchi M., Manda R., Ojima H., Tsukada K., Asao T. and Kuwano H. (2003). A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma. J. Surg. Oncol. 84, 24-30.
17. Keshgegian A.A., Johnston E. and Cnaan A. (1998). Bcl-2 oncoprotein positivity and high MIB-1 (Ki-67) proliferative rate are independent predictive markers for recurrence in prostate carcinoma. Am. J. Clin. Pathol. 110, 443-449.
18. Laskey R.A. and Madine M.A. (2003). A rotary pumping model for helicase function of MCM proteins at a distance from replication forks. EMBO Rep. 4, 26-30.
19. Li J.Y., Ershow A.G., Chen Z.J., Wacholder S., Li G.Y., Guo W., Li B. and Blot W.J. (1989). A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer 43, 755-761.
20. MacCallum D.E. and Hall P.A. (2000). The location of pKi67 in the outer dense fibrillary compartment of the nucleolus points to a role in ribosome biogenesis during the cell division cycle. J. Pathol. 190, 537-544.
21. Mangham D.C., Rowlands D.C., Newbold K.M., Reynolds G.M., Fielding J.W. and Hallissey M.T. (1994). Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value. J. Clin. Pathol. 47, 473-474.
22. Mulder A.H., Van Hootegem J.C., Sylvester R., ten Kate F.J., Kurth K.H., Ooms E.C. and Van der Kwast T.H. (1992). Prognostic factors in bladder carcinoma: histologic parameters and expression of a cell cycle-related nuclear antigen (Ki-67). J. Pathol. 166, 37-43.
23. Musahl C., Holthoff H.P., Lesch R. and Knippers R. (1998). Stability of the replicative Mcm3 protein in proliferating and differentiating human cells. Exp. Cell Res. 241, 260-264.
24. Parkin D.M., Bray F., Ferlay J. and Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74-108.
25. Prokhorova T.A. and Blow J.J. (2000). Sequential MCM/P1 subcomplex assembly is required to form a heterohexamer with replication licensing activity. J. Biol. Chem. 275, 2491-2498.
26. Ramnath N., Hernandez F.J., Tan D.F., Huberman J.A., Natarajan N., Beck A.F., Hyland A., Todorov I.T., Brooks J.S. and Bepler G. (2001). MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer. J. Clin. Oncol. 19, 4259-4266.
27. Reid B.J., Haggitt R.C., Rubin C.E., Roth G., Surawicz C.M., Van Belle G., Lewin K., Weinstein W.M., Antonioli D.A., Goldman H., McDonald W. and Owen D. (1988). Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum. Pathol. 19, 166-178.
28. Rodins K., Cheale M., Coleman N. and Fox S.B. (2002). Mini-chromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility. Clin. Cancer Res. 8, 1075-1081.
29. Sasano H., Miyazaki S., Gooukon Y., Nishihira T., Sawai T. and Nagura H. (1992). Expression of p53 in human esophageal carcinoma: an immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum. Pathol. 23, 1238-1243.
30. Shomori K., Nishihara K., Tamura T., Tatebe S., Horie Y., Nosaka K., Haruki T., Hamamoto Y., Shiomi T., Nakabayashi M. and Ito H. (2010). Geminin, Ki67, and minichromosome maintenance 2 in gastric hyperplastic polyps, adenomas, and intestinal-type carcinomas: pathobiological significance. Gastric Cancer 13, 177-185.
31. Sirieix P.S., O'Donovan M., Brown J., Save V., Coleman N. and Fitzgerald R.C. (2003). Surface expression of minichromosome maintenance proteins provides a novel method for detecting patients at risk for developing adenocarcinoma in Barrett's esophagus. Clin. Cancer Res. 9, 2560-2566.
32. Sobin L.H. and Witterkind C. (eds) (1997). UICC TNM Classification of malignant tumors, 5th edn. Wiley-Liss. New York.
33. Stillman B. (1996). Cell cycle control of DNA replication. Science 274, 1659-1664.
34. Stoeber K., Halsall I., Freeman A., Swinn R., Doble A., Morris L., Coleman N., Bullock N., Laskey R.A., Hales C.N. and Williams G.H. (1999). Immunoassay for urothelial cancers that detects DNA replication protein Mcm5 in urine. Lancet 354, 1524-1525.
35. Stoeber K., Tlsty T.D., Happerfield L., Thomas G.A., Romanov S., Bobrow L., Williams E.D. and Williams G.H. (2001). DNA replication licensing and human cell proliferation. J. Cell Sci. 114, 2027-2041.
36. Tachibana K.E., Gonzalez M.A. and Coleman N. (2005). Cell-cycle-dependent regulation of DNA replication and its relevance to cancer pathology. J. Pathol. 205, 123-129.
37. Tan D.F., Huberman J.A., Hyland A., Loewen G.M., Brooks J.S., Beck A.F., Todorov I.T. and Bepler G. (2001). MCM2--a promising marker for premalignant lesions of the lung: a cohort study. BMC Cancer 1, 6.
38. Todorov I.T., Werness B.A., Wang H.Q., Buddharaju L.N., Todorova P.D., Slocum H.K., Brooks J.S. and Huberman J.A. (1998). HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. Lab. Invest. 78, 73-78.
39. Tokuyasu N., Shomori K., Nishihara K., Kawaguchi H., Fujioka S., Yamaga K., Ikeguchi M. and Ito H. (2008). Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance. Gastric Cancer 11, 37-46.
40. Toschi L. and Bravo R. (1988). Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J. Cell Biol. 107, 1623-1628.
41. Tye B.K. (1999). MCM proteins in DNA replication. Annu. Rev. Biochem. 68, 649-686.
42. Wei W.Q., Abnet C.C., Lu N., Roth M.J., Wang G.Q., Dye B.A., Dong Z.W., Taylor P.R., Albert P., Qiao Y.L. and Dawsey S.M. (2005). Risk factors for oesophageal squamous dysplasia in adult inhabitants of a high risk region of China. Gut 54, 759-763.
43. Wharton S.B., Chan K.K., Anderson J.R., Stoeber K. and Williams G.H. (2001). Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. Neuropathol. Appl. Neurobiol. 27, 305-313.
44. Williams G.H., Romanowski P., Morris L., Madine M., Mills A.D., Stoeber K., Marr J., Laskey R.A. and Coleman N. (1998). Improved cervical smear assessment using antibodies against proteins that regulate DNA replication. Proc. Natl. Acad. Sci. USA 95, 14932-14937.
45. Zheng T., Mayne S.T., Holford T.R., Boyle P., Liu W., Chen Y., Mador M. and Flannery J. (1993). The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer 72, 330-340.